That is such a feeble letter by Cochrane. As if it was written by some trainee with literally no understanding of the situation. Doesn’t even qualify as weasel words.
Last edited:
Thanks @Caroline Struthers for your efforts. I can't say I'm surprised, given recent output of the Cochrane Infectious diseases section head. The whole organisation is a bad joke.
Well yes in that the new Exercise review if it ever happens would be not in that group. But no in that the current Exercise and CBT reviews they refuse to withdraw are still in that group. It's so completely illogical, I cannot fathom it.any movement in getting ME/CFS taken out of the Cochrane Common Mental Disorders Group?
It's so completely illogical, I cannot fathom it.
Well yes in that the new Exercise review if it ever happens would be not in that group. But no in that the current Exercise and CBT reviews they refuse to withdraw are still in that group. It's so completely illogical, I cannot fathom it.
Nope. they have got a special central editorial group working on it, so it is now outside the review group system. I don't know if this has ever happened to any other reviews....I doubt it. the review group system is totally stupid anyway.Do we know what group it would be in?
Hello All
I had a reply today to my request to Cochrane to withdraw the Exercise and CBT reviews which I made in November. The response was very vague, so I replied asking for clarification - see below
From: Rachel Marshall <rmarshall@cochrane.org>
Sent: 01 February 2021 17:35
To: Caroline Struthers <caroline.struthers@csm.ox.ac.uk>
Cc: Karla Soares-Weiser <ksoares-weiser@cochrane.org>
Subject: RE: Request for withdrawal of reviews Exercise therapy for chronic fatigue syndrome and CBT
for chronic fatigue syndrome
Dear Caroline,
Thank you again for your email regarding the Cochrane reviews on exercise therapy and cognitive
behavioural therapy (CBT) for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
A sub-group of the Cochrane Editorial Board and a Co-ordinating editor have reviewed and discussed the
information from the updated NICE guideline under consultation on ME/CFS, and the associated NICE
evidence review on non-pharmacological management [review G]. The editors have agreed that the
information within does not meet Cochrane’s criteria for a serious error, and both reviews will remain
on the Cochrane Library. The two Cochrane reviews each have an editorial note within the abstract,
explaining the current status of the review. Cochrane will update the editorial note for the CBT review to
further clarify that the strength of evidence has not been evaluated using GRADE methodology, and this
change to the editorial note will be made within the next few days.
With best regards, Rachel
Rachel Marshall
Senior Editorial Officer
Editorial & Methods Department | Cochrane Central Executive
From: Caroline Struthers
Sent: 01 February 2021 21:38
To: Rachel Marshall
Cc: Karla Soares-Weiser
Subject: RE: Request for withdrawal of reviews Exercise therapy for chronic fatigue syndrome
and CBT for chronic fatigue syndrome
Hi Rachel
“The editors have agreed that the information within [the draft NICE guideline] does not meet
Cochrane’s criteria for a serious error”
This sentence doesn’t make sense.
I notified the Editor in Chief that following the conclusions of the reviews could lead to patient harm
which is one of Cochrane’s definitions of a serious error.
Can you confirm that the message below means that the editors have concluded that following the
conclusions of either of these reviews could not lead to patient harm.
This is despite the new draft NICE guideline recommending that neither intervention should be
recommended due to extremely poor evidence of effectiveness, and with recent reliable evidence of
harm.
Best wishes
Caroline
Caroline Struthers
Senior EQUATOR Research Fellow
. Cochrane will update the editorial note for the CBT review to
further clarify that the strength of evidence has not been evaluated using GRADE methodology, and this
change to the editorial note will be made within the next few days.
I notified the Editor in Chief that following the conclusions of the reviews could lead to patient harm
which is one of Cochrane’s definitions of a serious error.
NICE looked at outcomes from various non pharmacological trials, with 89% rated very low quality and the rest rate low quality. Did anyone manage to work out which outcomes related to which trials?They should really put a much stronger note. If I remember correctly the rated PACE as high quality and NICE using GRADE rated it as low quality so they shouldn't just say that the evidence has not been evaluated using GRADE they should point out that when others used this methodology they got very different results than in this Cochrane review.
@Valerie Eliot Smith are you following this thread? Do you think there could be a legal case against Cochrane?I do wonder if they could he found neglagent if someone was harmed by GET but I suspect its look complex an accountability chain.
They should really put a much stronger note. If I remember correctly the rated PACE as high quality and NICE using GRADE rated it as low quality so they shouldn't just say that the evidence has not been evaluated using GRADE they should point out that when others used this methodology they got very different results than in this Cochrane review.
It would be interesting to get more details as to what they did consider. They are fully aware that harm could be caused and have chosen to ignore it before.
I wonder if it is worth making the point that they claim a new review will happen but there is no evidence that anything is actually happening.
I do wonder if they could he found neglagent if someone was harmed by GET but I suspect its look complex an accountability chain.
Likely after the fact but Cochrane is an independent non-profit, it is not regulated and can basically publish what they want as they see fit. Their influence comes from the trust medical professionals and organizations put in them, they have no official power. Clearly misplaced trust but whatever, the organizations make their own choices and are not bound by any obligation to do any better.I'd like to see a legal challenge.
Although maybe we could learn from the best and follow their playbook. First spend time doing lunch with all the right people and whisper our demands for the system to be altered in a way that will effectively give us a certain win.
I will try and contact @Valerie Eliot Smith direct about this as the Charity Commission advised either re-engaging with Cochrane (tried that) or seeking legal advice as a next step. What about Monbiot?NICE looked at outcomes from various non pharmacological trials, with 89% rated very low quality and the rest rate low quality. Did anyone manage to work out which outcomes related to which trials?
@Valerie Eliot Smith are you following this thread? Do you think there could be a legal case against Cochrane?
NICE looked at outcomes from various non pharmacological trials, with 89% rated very low quality and the rest rate low quality. Did anyone manage to work out which outcomes related to which trials?